Search results
Advancements in protein engineering offer hope for cancer therapies
Medical Xpress· 1 hour agoNew research from Jin Kim Montclare, Professor of Chemical and Biomolecular Engineering, may lend...
Understanding the immune system's 'big eater': New insights into macrophage behavior in cancer...
Medical Xpress· 21 minutes agoA new study from SDSU's Department of Chemistry, Biochemistry and Physics, led by professor Adam Hoppe, shows a greater understanding of macrophages—one of the immune system's ...
Sodas sold in restaurants across the country recalled over dye linked to cancer: FDA
Local 12 Cincinnati· 2 days agoA soda company has recalled several products that were sold in restaurants across the country....
Colorectal cancer: Immunotherapy drug may help patients avoid surgery
Medical News Today· 1 day agoPast research shows that treating MMR deficient/MSI-High colorectal cancer tumors can sometimes be...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 hours agoAnd, last month, Pfizer unveiled positive results from a lung cancer study. The company tested its ...
Sana Al Sukhun, MD, on Metastatic Breast Cancer Treatment in Lower-Income Settings
MedPage Today· 3 days agoTreatment guidelines for patients with metastatic breast cancer often recommend tests, drugs, and...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 4 days agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
Top Advisors Pledge $500,000 To Fund Breast Cancer Drug Therapy
Forbes· 11 hours agoTop Forbes | SHOOK financial advisors and Wall Street investment firms have pledged more than...
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 3 days agoThe study included 42 patients suffering from mismatch repair deficient (dMMR) locally advanced...
Geron surges after winning first US FDA approval for blood disorder drug
Reuters· 2 hours ago, opens new tab surged more than 30% on Friday, a day after the company gained its first approval...